93 related articles for article (PubMed ID: 20413369)
21. Skin metastases of malignant melanoma: a clinical and prognostic survey.
Savoia P; Fava P; Nardò T; Osella-Abate S; Quaglino P; Bernengo MG
Melanoma Res; 2009 Oct; 19(5):321-6. PubMed ID: 19641475
[TBL] [Abstract][Full Text] [Related]
22. The 'Sentinel Node' Concept: More Questions Raised than Answers Provided?
Schlag PM
Oncologist; 1998; 3(5):VI-VII. PubMed ID: 10388128
[TBL] [Abstract][Full Text] [Related]
23. Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma.
Barnhill RL; Fandrey K; Levy MA; Mihm MC; Hyman B
Lab Invest; 1992 Sep; 67(3):331-7. PubMed ID: 1383607
[TBL] [Abstract][Full Text] [Related]
24. Sentinel node biopsy in melanoma delays recurrence but does not change melanoma-related survival: a retrospective analysis of 673 patients.
Gutzmer R; Al Ghazal M; Geerlings H; Kapp A
Br J Dermatol; 2005 Dec; 153(6):1137-41. PubMed ID: 16307648
[TBL] [Abstract][Full Text] [Related]
25. Vascular endothelial growth factor-C expression correlates with lymph node localization of human melanoma metastases.
Schietroma C; Cianfarani F; Lacal PM; Odorisio T; Orecchia A; Kanitakis J; D'Atri S; Failla CM; Zambruno G
Cancer; 2003 Aug; 98(4):789-97. PubMed ID: 12910524
[TBL] [Abstract][Full Text] [Related]
26. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma.
Doubrovsky A; De Wilt JH; Scolyer RA; McCarthy WH; Thompson JF
Ann Surg Oncol; 2004 Sep; 11(9):829-36. PubMed ID: 15313732
[TBL] [Abstract][Full Text] [Related]
27. Angiogenesis and lymphangiogenesis of skin cancers.
Dadras SS; Detmar M
Hematol Oncol Clin North Am; 2004 Oct; 18(5):1059-70, viii. PubMed ID: 15474335
[TBL] [Abstract][Full Text] [Related]
28. The correlation of regression in primary melanoma with sentinel lymph node status.
Kaur C; Thomas RJ; Desai N; Green MA; Lovell D; Powell BW; Cook MG
J Clin Pathol; 2008 Mar; 61(3):297-300. PubMed ID: 17675538
[TBL] [Abstract][Full Text] [Related]
29. Circulating vascular endothelial growth factor in cutaneous malignant melanoma.
Pelletier F; Bermont L; Puzenat E; Blanc D; Cairey-Remonnay S; Mougin C; Laurent R; Humbert P; Aubin F
Br J Dermatol; 2005 Apr; 152(4):685-9. PubMed ID: 15840099
[TBL] [Abstract][Full Text] [Related]
30. Outcome of patients with melanoma and histologically negative sentinel lymph nodes: one institution's experience.
De Giorgi V; Leporatti G; Massi D; Lo Russo G; Sestini S; Dini M; Lotti T
Oncology; 2007; 73(5-6):401-6. PubMed ID: 18515980
[TBL] [Abstract][Full Text] [Related]
31. Vulvar melanoma: is there a role for sentinel lymph node biopsy?
de Hullu JA; Hollema H; Hoekstra HJ; Piers DA; Mourits MJ; Aalders JG; van der Zee AG
Cancer; 2002 Jan; 94(2):486-91. PubMed ID: 11905414
[TBL] [Abstract][Full Text] [Related]
32. The biology of melanoma micrometastases.
Barnhill RL
Recent Results Cancer Res; 2001; 158():3-13. PubMed ID: 11092028
[TBL] [Abstract][Full Text] [Related]
33. Stochastic relationship between the growth fraction and vascularity of thin malignant melanomas.
Piérard GE; Piérard-Franchimont C
Eur J Cancer; 1997 Oct; 33(11):1888-92. PubMed ID: 9470852
[TBL] [Abstract][Full Text] [Related]
34. Tumor vascularity, proliferation, and apoptosis in human melanoma micrometastases and macrometastases.
Barnhill RL; Piepkorn MW; Cochran AJ; Flynn E; Karaoli T; Folkman J
Arch Dermatol; 1998 Aug; 134(8):991-4. PubMed ID: 9722729
[TBL] [Abstract][Full Text] [Related]
35. Vascular retardation in dormant growth-stunted malignant melanomas.
Piérard-Franchimont C; Henry F; Heymans O; Piérard GE
Int J Mol Med; 1999 Oct; 4(4):403-6. PubMed ID: 10493982
[TBL] [Abstract][Full Text] [Related]
36. Vascularity and fractal dimension of the dermo-epidermal interface in guttate and plaque-type psoriasis.
Uhoda I; Piérard GE; Piérard-Franchimont C; Arrese JE; Goffin V; Nikkels A; Paquet P; Quatresooz P
Dermatology; 2005; 210(3):189-93. PubMed ID: 15785045
[TBL] [Abstract][Full Text] [Related]
37. Angiogenesis correlates with metastasis in melanoma.
Neitzel LT; Neitzel CD; Magee KL; Malafa MP
Ann Surg Oncol; 1999; 6(1):70-4. PubMed ID: 10030417
[TBL] [Abstract][Full Text] [Related]
38. The Role of Neutrophilic Inflammation, Angiotropism, and Pericytic Mimicry in Melanoma Progression and Metastasis.
Landsberg J; Tüting T; Barnhill RL; Lugassy C
J Invest Dermatol; 2016 Feb; 136(2):372-377. PubMed ID: 26802235
[TBL] [Abstract][Full Text] [Related]
39. Malignant melanoma: from cell kinetics to micrometastases.
Quatresooz P; Piérard GE
Am J Clin Dermatol; 2011 Apr; 12(2):77-86. PubMed ID: 21142291
[TBL] [Abstract][Full Text] [Related]
40. Angiogenesis in primary tumor cells of metastatic and nonmetastatic malignant melanoma.
Mowlavi A; Malafa MP
Plast Reconstr Surg; 2000 Aug; 106(2):514. PubMed ID: 10946963
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
